(Q34394426)

1 August 2017

title

Liver resections in metastatic gastric cancer (English)

1 reference

1 August 2017

Sid P Kerkar

1

1 reference

1 August 2017

Clinton D Kemp

series ordinal

2

1 reference

1 August 2017

Itzhak Avital

series ordinal

3

1 reference

1 August 2017

publication date

1 November 2010

1 reference

1 August 2017

published in

Hepato Pancreato Biliary

1 reference

1 August 2017

volume

12

1 reference

1 August 2017

issue

9

1 reference

1 August 2017

page(s)

589-596

1 reference

The GYMSSA trial: a prospective randomized trial comparing gastrectomy, metastasectomy plus systemic therapy versus systemic therapy alone

1 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999785

6 July 2018

Cancer statistics, 2009

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999785

Surgical therapy for colorectal metastases to the liver

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999785

Favorable indications for hepatectomy in patients with liver metastasis from gastric cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999785

Phase II trial of irinotecan plus oxaliplatin and 5-fluorouracil/leucovorin in patients with untreated metastatic gastric adenocarcinoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999785

Patterns of initial recurrence in completely resected gastric adenocarcinoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999785

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999785

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999785

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999785

Phase II trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) as first-line treatment for advanced gastric cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999785

Liver resection for metastatic gastric cancer.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999785

Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999785

Analysis of the prognostic factors for liver metastasis of gastric cancer after hepatic resection: a multi-institutional study of the indications for resection

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999785

Surgical treatment of neuroendocrine metastases to the liver: a plea for resection to increase survival

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999785

Clinicopathological features and outcome of hepatic resection for liver metastasis from gastric cancer.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2999785

Synchronous, metachronous, and multiple hepatic resections of liver tumors originating from primary gastric tumors

27 October 2018

1 reference

12 December 2020

Hepatic resection of liver metastases from gastric carcinoma

1 reference

12 December 2020

Resection of liver metastases from a noncolorectal primary: indications and results based on 147 monocentric patients

1 reference

12 December 2020

Outcome of hepatic resection for metastatic gastric cancer

1 reference

12 December 2020

Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model

1 reference

12 December 2020

Surgical management for metastatic liver tumors

1 reference

12 December 2020

Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: the V-325 Study Group

1 reference

12 December 2020

Liver resection for metastatic gastric cancer: experience with 42 patients including eight long-term survivors

1 reference

12 December 2020

Survival benefit of combined curative resection of the stomach (D2 resection) and liver in gastric cancer patients with liver metastases

1 reference

12 December 2020

The role of hepatectomy for patients with liver metastases of gastric cancer

1 reference

12 December 2020

Analysis of the prognostic factors and evaluation of surgical treatment for synchronous liver metastases from gastric cancer

1 reference

12 December 2020

Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors

1 reference

12 December 2020

Resection of liver metastasis from gastric adenocarcinoma

1 reference

12 December 2020

Benefits and limits of hepatic resection for gastric metastases

1 reference

12 December 2020

A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma

1 reference

12 December 2020

Hepatic resection for metastatic tumors from gastric cancer

1 reference

12 December 2020

Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade

1 reference

12 December 2020

Analysis of hepatic resection of metastasis originating from gastric adenocarcinoma

1 reference

12 December 2020

Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients

1 reference

12 December 2020

10.1111/J.1477-2574.2010.00224.X

Identifiers

DOI

1 reference

1 August 2017

1 reference

1 August 2017

1 reference